Ledger.Open graph →
SEC Form D · filed March 14, 2014

TRANSGENOMIC INC

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OMAHA, NE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Mark P. Colonnese · Omaha, NEExecRobert M. Patzig · Omaha, NEDirectorRodney S. Markin · Omaha, NEDirectorPaul Kinnon · Omaha, NEExec · DirectorAntonius P. Schuh · Omaha, NEDirectorDoit L. Koppler Ii · Omaha, NEDirectorMark A. Kielek · New Providence, NJDirectorRobert A. Flanagan · New Providence, NJDirectorRobert A. Croce · New Providence, NJExec · DirectorOppenheimer & Company Inc · New York, NYExecOppenheimer Asset Management Inc · New York, NYDirectorDoit L. Koppler Ii · Omaha, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗